BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30316961)

  • 1. The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation.
    Bloemen S; Zwaveling S; Douxfils J; Roest M; Kremers R; Mullier F
    Thromb Res; 2018 Nov; 171():160-166. PubMed ID: 30316961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation.
    Božič Mijovski M; Malmström RE; Vene N; Antovic JP; Mavri A
    Sci Rep; 2021 Mar; 11(1):5920. PubMed ID: 33723299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
    Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.
    Takeshita S; Tanaka KA; Sawa T; Sanda M; Mizobe T; Ogawa S
    Anesth Analg; 2020 Feb; 130(2):535-541. PubMed ID: 31490820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency.
    Gribkova IV; Lipets EN; Rekhtina IG; Bernakevich AI; Ayusheev DB; Ovsepyan RA; Ataullakhanov FI; Sinauridze EI
    Sci Rep; 2016 Jul; 6():29242. PubMed ID: 27377013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.
    Jacquemin M; Toelen J; Schoeters J; van Horenbeeck I; Vanlinthout I; Debasse M; Peetermans M; Vanassche T; Peerlinck K; van Ryn J; Verhamme P
    J Thromb Haemost; 2015 Nov; 13(11):2087-92. PubMed ID: 26347330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
    Green L; Lawrie AS; Patel R; Stephens RC; Mackie IJ; Chitolie A; Haddad FS; Machin SJ
    Thromb Res; 2012 Nov; 130(5):775-9. PubMed ID: 22245224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
    Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
    J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay.
    Wong PC; White A; Luettgen J
    Hosp Pract (1995); 2013 Feb; 41(1):19-25. PubMed ID: 23466964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma.
    Zhang C; Zhang P; Li H; Han L; Zhang L; Zhang L; Yang X
    Thromb Res; 2018 May; 165():38-43. PubMed ID: 29558660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
    Glund S; Stangier J; van Ryn J; Schmohl M; Moschetti V; Haazen W; De Smet M; Gansser D; Norris S; Lang B; Reilly P; Kreuzer J
    Clin Pharmacokinet; 2017 Jan; 56(1):41-54. PubMed ID: 27317414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Dabigatran Is an Effective Anticoagulant for Simulated Cardiopulmonary Bypass Using Human Blood.
    Nadtochiy SM; Baldzizhar A; Stefanos T; Feng C; O'Leary KE; Jones-Smith KL; Angona RE; Eaton MP
    Anesth Analg; 2021 Feb; 132(2):566-574. PubMed ID: 32833714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of thrombin generation by TFPI in plasma without and with heparin.
    Brodin E; Appelbom H; Osterud B; Hilden I; Petersen LC; Hansen JB
    Transl Res; 2009 Mar; 153(3):124-31. PubMed ID: 19218095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban.
    Herrmann R; Thom J; Wood A; Phillips M; Muhammad S; Baker R
    Thromb Haemost; 2014 May; 111(5):989-95. PubMed ID: 24352511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time.
    Dubé C; Douketis JD; Moffat KA; Schulman S; Blais N
    Thromb Res; 2018 Nov; 171():62-67. PubMed ID: 30261356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations.
    Božič-Mijovski M; Malmström RE; Malovrh P; Antovic JP; Vene N; Šinigoj P; Mavri A
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):446-51. PubMed ID: 26392631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation.
    Jaffer IH; Stafford AR; Fredenburgh JC; Whitlock RP; Chan NC; Weitz JI
    J Am Heart Assoc; 2015 Aug; 4(8):e002322. PubMed ID: 26304938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.